This week on Careers in Discovery, we’re joined by Tommi Kainu, Chairman of GlyProVac, a Biotech developing bacterial vaccines with the potential to tackle antimicrobial resistance.

Tommi’s career has taken him from medicine and research to consulting at BCG and leadership roles in Biotech. He shared insights on GlyProVac’s work, why commercial thinking is key in drug development, and lessons from his time at Bavarian Nordic - including the unexpected rise of the MPOX vaccine.

His advice for scientists moving into industry? Start with the end in mind.

A great conversation on science, strategy, and the business of Biotech.